MARKET

BMY

BMY

Bristol-Myers Squibb Co
NYSE
58.80
+0.46
+0.79%
After Hours: 59.08 +0.28 +0.47% 19:50 11/20 EST
OPEN
59.16
PREV CLOSE
58.34
HIGH
59.81
LOW
58.70
VOLUME
12.63M
TURNOVER
--
52 WEEK HIGH
67.94
52 WEEK LOW
43.34
MARKET CAP
120.19B
P/E (TTM)
13.03
1D
5D
1M
3M
1Y
5Y
1D
Bristol Myers Squibb's Growth Portfolio Just Hit $7.7 Billion. Is This Cheap Pharma Stock a No-Brainer Buy?
The Motley Fool · 1d ago
Erasca: 'Buy' On Expanded KRAS Targeting ERAS-4001 And Bristol-Myers Squibb Collaboration Tie-Up
Seeking Alpha · 1d ago
4 Dividend Stocks Wall Street Gave Up On With Balance Sheets Built to Recover
24/7 Wall St. · 1d ago
Bristol-Myers Squibb (BMY) Gets a Hold from Leerink Partners
TipRanks · 2d ago
What Does Bristol Myers Squibb (BMY) Clinical Momentum Mean For Its Growth Story?
Simply Wall St · 2d ago
Bipartisan panel says China 'doubling down' on control of pharma supply chain
Seeking Alpha · 2d ago
Halozyme Therapeutics: 3 Technologies, Multiple Big Pharma Partnerships
Seeking Alpha · 2d ago
3 Big Pharma Dividend Stocks Built for Retirement Income
24/7 Wall St. · 2d ago
More
About BMY
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development, and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Orencia (abatacept), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Breyanzi (lisocabtagene maraleucel), Opdualag (nivolumab and relatlimab-rmbw), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), Sotyktu (deucravacitinib), Krazati (adagrasib), and Cobenfy (xanomeline and trospium chloride). Its other growth products include Augtyro, Onureg, Inrebic, Nulojix, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension).

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: BMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMY stock methods without spending real money on the virtual paper trading platform.